Real-time enrollment status for this alpha-1 antitrypsin deficiency clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 10:46 AM UTC
| NCT Number | NCT05677971 |
| Recruiting Status | Recruiting |
| Condition | Alpha-1 Antitrypsin Deficiency |
| Phase | PHASE3 |
| Target Enrollment | 160 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | May 13, 2026 (May 13, 2026) |
As of July 19, 2026: Clinical trial NCT05677971 is currently recruiting participants. This phase3 study for alpha-1 antitrypsin deficiency is actively seeking new participants at 37 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05677971 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05677971 was last updated May 13, 2026 (May 13, 2026). HelloStudys verifies this status automatically.